baicalin has been researched along with Uterine Cervical Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Q; Xu, H; Zhao, X | 1 |
Angelov, B; Chen, Y; Drechsler, M; Garamus, VM; Liu, J; Minh, LV; Willumeit-Römer, R; Zou, A | 1 |
2 other study(ies) available for baicalin and Uterine Cervical Neoplasms
Article | Year |
---|---|
Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Flavonoids; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Phosphorylation; Protein Kinase C; Signal Transduction; STAT3 Transcription Factor; Survivin; Uterine Cervical Neoplasms | 2018 |
Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cryoelectron Microscopy; Drug Liberation; Drug Stability; Female; Flavonoids; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Liposomes; Microscopy, Confocal; Microscopy, Electron, Transmission; Polyethylene Glycols; Scattering, Small Angle; Uterine Cervical Neoplasms; X-Ray Diffraction | 2016 |